MedTrace Logo

Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study

NCT06429943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47

Last updated 2024-05-28

No results posted yet for this study

Summary

Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.

Conditions

  • SAH (Subarachnoid Hemorrhage)

Sponsors & Collaborators

  • Pomeranian Medical University Szczecin

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-10-15
Completion
2023-01-10

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429943 on ClinicalTrials.gov